3-(2,2,2-trimethylhydrazine)propionate has been researched along with Apoplexy in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belousova, YD; Reznik, EY; Tynterova, AM | 1 |
| Feng, L; Guo, Z; Li, D; Li, Z; Liu, J; Liu, X; Qu, F; Xia, J; Yan, X; Zhang, B; Zhang, G; Zhang, X; Zhang, Z; Zhao, G; Zhao, H; Zhao, J; Zhu, Y | 1 |
| Markevich, YN; Nevzorov, NM | 1 |
| Duburs, G; Isajevs, S; Kalvinsh, I; Klusa, V; Pupure, J; Rumaks, J; Svirskis, S | 1 |
2 trial(s) available for 3-(2,2,2-trimethylhydrazine)propionate and Apoplexy
| Article | Year |
|---|---|
Efficacy and safety of mildronate for acute ischemic stroke: a randomized, double-blind, active-controlled phase II multicenter trial.
Topics: Aged; Brain Ischemia; Cardiovascular Agents; Double-Blind Method; Female; Humans; Male; Methylhydrazines; Middle Aged; Stroke; Treatment Outcome | 2013 |
[Efficacy and safety of mildronate in emergency medical care].
Topics: Adult; Aged; Aged, 80 and over; Brain Ischemia; Emergency Treatment; Female; Humans; Injections, Intravenous; Male; Methylhydrazines; Middle Aged; Stroke; Treatment Outcome | 2013 |
2 other study(ies) available for 3-(2,2,2-trimethylhydrazine)propionate and Apoplexy
| Article | Year |
|---|---|
[Clinical characteristics and metabolic therapy of fatigue in the acute and early recovery periods of ischemic stroke].
Topics: Aged; Asthenia; Fatigue; Humans; Ischemic Stroke; Middle Aged; Stroke; Syndrome | 2023 |
Search for stroke-protecting agents in endothelin-1-induced ischemic stroke model in rats.
Topics: Animals; Dihydropyridines; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Therapy, Combination; Endothelin-1; Male; Methylhydrazines; Neuroprotective Agents; Rats; Rats, Wistar; Stroke | 2012 |